JAPAN CLINICAL CANCER RESEARCH ORGANIZATION
🇯🇵Japan
A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab
Phase 2
- Conditions
- Colorectal Cancer
- Interventions
- Biological: bevacizumabBiological: cetuximab
- First Posted Date
- 2015-08-05
- Last Posted Date
- 2015-08-05
- Lead Sponsor
- Japan Clinical Cancer Research Organization
- Target Recruit Count
- 360
- Registration Number
- NCT02515734
Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2012-11-27
- Lead Sponsor
- Japan Clinical Cancer Research Organization
- Target Recruit Count
- 45
- Registration Number
- NCT01227239
- Locations
- 🇯🇵
Nagoya University Graduate School of Medicine, Nagoya, Japan
🇯🇵Osaka Medical College, Osaka, Japan
🇯🇵Tokyo University, Tokyo, Japan
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
- First Posted Date
- 2008-03-20
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- Japan Clinical Cancer Research Organization
- Target Recruit Count
- 300
- Registration Number
- NCT00639327
- Locations
- 🇯🇵
Hirosahi University Graduate School of Medicine, Hirosaki, Aomori, Japan
🇯🇵Fukuyama City Hospital, Fukuyama, Hiroshima, Japan
🇯🇵Asahikawa Medical College Hospital, Asahikawa, Hokkaido, Japan
GEM vs GEM+TS-1 for Advanced Pancreatic Cancer
- First Posted Date
- 2007-08-09
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- Japan Clinical Cancer Research Organization
- Target Recruit Count
- 110
- Registration Number
- NCT00514163
- Locations
- 🇯🇵
Cancer Institute Ariake Hospital, Tokyo, Japan
Clinical Trial of Chemosensitivity Test
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2011-06-29
- Lead Sponsor
- Japan Clinical Cancer Research Organization
- Target Recruit Count
- 300
- Registration Number
- NCT00287755
- Locations
- 🇯🇵
Kanazawa Medical University Hospital, Kanazawa, Ishikawa, Japan
🇯🇵St. Marianna University, School of Medicine, Kawasaki, Kanagawa, Japan
🇯🇵Osaka Medical College Hospital, Takatsuki, Osaka, Japan
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- Japan Clinical Cancer Research Organization
- Target Recruit Count
- 628
- Registration Number
- NCT00287768
- Locations
- 🇯🇵
Kanazawa Medical University Hospital, Kawakita, Ishikawa, Japan
🇯🇵Iwate Medical University Hospital, Morioka, Iwate, Japan
🇯🇵Kitasato University East Hospital, Sagamihara, Kanagawa, Japan
© Copyright 2025. All Rights Reserved by MedPath